Randomised feasibility trial to compare three standard of care chemotherapy regimens for early stage triple-negative breast cancer (REaCT-TNBC trial)

INTRODUCTION: Despite the importance of chemotherapy in the treatment of early stage triple negative breast cancer (TNBC), no one optimal regimen has been identified. We conducted a pilot trial comparing outcomes for the three most commonly used chemotherapy regimens to assess the feasibility of con...

Descripción completa

Detalles Bibliográficos
Autores principales: Hilton, John, Stober, Carol, Mazzarello, Sasha, Vandermeer, Lisa, Fergusson, Dean, Hutton, Brian, Clemons, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057636/
https://www.ncbi.nlm.nih.gov/pubmed/30040817
http://dx.doi.org/10.1371/journal.pone.0199297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057636/
https://www.ncbi.nlm.nih.gov/pubmed/30040817
http://dx.doi.org/10.1371/journal.pone.0199297

Ejemplares similares